✦ LIBER ✦

284 Differential Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

✍ Scribed by Pommier, Y.; Huang, S.H.; Das, B.B.; Renaud, A.; Zhang, Y.; Takeda, S.H.; Doroshow, J.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of matrix metalloproteinase-2

✍ Adrian C. Nicolescu; Andrew Holt; Arulmozhi D. Kandasamy; Pal Pacher; Richard Sc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 317 KB

The Role of PARP-1 and PARP-2 Enzymes in

✍ Péter Bai; Carles Cantó 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 619 KB

Rational design and synthesis of new PAR

✍ Leonid V. Romashov; Alexey A. Zeifman; Alexandra L. Zakharenko; Fedor N. Novikov 📂 Article 📅 2012 🏛 Royal Society of Chemistry 🌐 English ⚖ 344 KB

Doxorubicin-induced suppression of poly(

✍ Tomasz Zaremba; Huw Thomas; Michael Cole; Elizabeth R. Plummer; Nicola J. Curtin 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 283 KB

PARP inhibitors and the treatment of bre

✍ Kristine M Frizzell, W Lee Kraus 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 49 KB

Pre-clinical and clinical evaluation of

✍ C. Powell; C. Mikropoulos; S.B. Kaye; C.M. Nutting; S.A. Bhide; K. Newbold; K.J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 713 KB